“90% Success in Beating Cancer: Israel’s Life-Changing Advancements”

“90% Success in Beating Cancer: Israel's Life-Changing Advancements"

Multiple myeloma is a type of cancer that affects plasma cells and is a widespread hematological disease. These are special white blood cells that produce antibodies that assist to defend our body against infections.

At the myeloma stage, these cells start multiplying greatly, leading to congestion in the bone marrow. overall production of White blood cells, platelets, and red blood cell production is halted up to a certain stage. As a result, this can be harmful to the health of a person.

Unprecedented Results and Impact on Patients

This ground-breaking treatment, produced through in-depth research in the hospital’s bone-marrow transplant and immunotherapy department, has produced extraordinary outcomes. This gives hope to patients who were considered incurable.

This treatment Uses an advanced genetic engineering technology called CAR-T (Chimeric Antigen Receptor T-Cell Therapy). This treatment uses the power of the patient’s own immune system to fight against cancer. 

The oncologist confirmed that of the patient treated. Seventy-Four patients treated at  Hadassah experienced full recovery with over 90% amazing results.

The Future of Cancer Treatment

patients with multiple myeloma faced a dim future perspective with a life expectancy of just two years. Thanks to this discovery, this groundbreaking advancement has completely removed those expectations. This gives patients a renewed sense of hope as they now have a long life span and an improved quality of life.

Professor Polina Stepansky expressed great enthusiasm about the future, expressing the impressive results of CAR-T treatments. This will offer the patients the ability to live longer in a healthy lifestyle.

In conclusion, this discovery marks an important event in the fight against multiple myeloma. This provides new hope and fresh thoughts about the possibility for patients and their families. The groundbreaking research done at Hadassah University Medical Center sets a model for the capacity of genetic engineering technology. This will change the outlook of cancer treatment and increase patient recovery levels.

Related Articles